Analyst Ratings for MedAssets (MDAS) [Neutrals]
MDAS Rating Summary
MDAS Price Target Summary
- Highest: $19.00 (UBS)
- Lowest: $13.00 (Sterne Agee)
- Average: $15.25
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$15.25 (-12.7%)
Avg. $ Target:
$15.25 (-12.7%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/27/2012 | Caris & Co. | Downgrade | Average (N/A) |
14.00 (N/A) |
14.10 | 17.47 | 23.9% | Details |
| 7/15/2011 | Goldman Sachs | New Coverage | Neutral (N/A) |
N/A (N/A) |
13.19 | 17.47 | 32.45% | Details |
| 6/9/2011 | Leerink Swann | Downgrade | Market Perform (N/A) |
N/A (N/A) |
13.61 | 17.47 | 28.36% | Details |
| 2/25/2011 | Avondale Partners | Downgrade | Market Perform (N/A) |
N/A (N/A) |
14.96 | 17.47 | 16.78% | Details |
| 2/25/2011 | William Blair | Downgrade | Market Perform (N/A) |
N/A (N/A) |
15.40 | 17.47 | 13.44% | Details |
| 2/25/2011 | Stifel Nicolaus | Downgrade | Hold (N/A) |
N/A (N/A) |
15.40 | 17.47 | 13.44% | Details |
| 2/25/2011 | ThinkEquity | Downgrade | Hold (N/A) |
N/A (N/A) |
15.40 | 17.47 | 13.44% | Details |
| 2/25/2011 | Citi | Downgrade | Neutral (N/A) |
N/A (N/A) |
15.40 | 17.47 | 13.44% | Details |
| 2/25/2011 | Deutsche Bank » Updated 2/24/2012 |
Downgrade | Hold (N/A) |
13.50 (N/A) |
15.40 | 17.47 | 13.44% | Details |
| 2/15/2011 | Morgan Stanley | New Coverage | Equalweight (N/A) |
N/A (N/A) |
20.84 | 17.47 | -16.17% | Details |
| 1/5/2011 | Wells Fargo | Downgrade | Market Perform (N/A) |
N/A (N/A) |
19.61 | 17.47 | -10.91% | Details |
| 12/6/2010 | JPMorgan | New Coverage | Neutral (N/A) |
N/A (N/A) |
19.48 | 17.47 | -10.32% | Details |
